USBC, Inc.·4

Mar 26, 4:09 PM ET

PAYNE KITTY B 4

4 · USBC, Inc. · Filed Mar 26, 2026

Research Summary

AI-generated summary of this filing

Updated

USBC CFO Kitty Payne Receives Repriced Options

What Happened

  • Kitty B. Payne (CFO, Treasurer, Secretary of USBC, Inc.) was the reported party in a repricing of outstanding stock options covering 3,750,000 shares. The Form 4 shows a disposition of the old option grant and the simultaneous grant/acquisition of the repriced option (both recorded at $0 on the form). Per the filing, the exercise price for the repriced options was reduced from $1.10 to $0.37 per share.
  • This was a derivative/option repricing (not a cash purchase or a sale of common stock) and did not involve an immediate exercise for shares or proceeds. The repriced options will vest 25% on the one-year anniversary of their respective grant dates and then in quarterly installments over the next three years.

Key Details

  • Transaction date: March 18, 2026; Form filed March 26, 2026 (8 days after the transaction — Form 4s are typically due within two business days, so this filing appears later than usual).
  • Instruments affected: Options covering 3,750,000 shares; exercise price reduced from $1.10 to $0.37 per share (footnotes F1 and F2).
  • Reporting entries: Form shows a disposition of the prior option and a grant/acquisition of the repriced option (both reported at $0 as derivative transactions).
  • Vesting: 25% after one year from each grant date, then quarterly over three years (per footnotes).
  • Shares owned after the transaction: not disclosed in the filing.

Context

  • Repricing replaces older option terms with lower exercise prices; it is a corporate compensation action rather than an insider purchase or sale of common stock. The filing does not show a cashless exercise or sale of underlying shares, so no immediate change in common-share holdings or proceeds are reported.
  • As this involves an executive-level insider (CFO), investors may track future filings for exercises or sales, but the repricing itself is a contractual change to option economics rather than an outright market transaction.

Insider Transaction Report

Form 4
Period: 2026-03-18
PAYNE KITTY B
CFO, Treasurer, Secretary
Transactions
  • Disposition to Issuer

    Option to Purchase Common Stock

    [F1]
    2026-03-183,750,0000 total
    Exercise: $1.10Exp: 2035-10-07Common Stock (3,750,000 underlying)
  • Award

    Option to Purchase Common Stock

    [F2]
    2026-03-18+3,750,0003,750,000 total
    Exercise: $0.37Exp: 2036-03-18Common Stock (3,750,000 underlying)
Footnotes (2)
  • [F1]The transactions reported involved the repricing of outstanding stock options to purchase 3,750,000 shares of common stock of USBC, Inc. (the "Company") pursuant to the Amended and Restated USBC, Inc. 2021 Equity Incentive Plan (the "Amended and Restated 2021 Plan"), reflecting the options granted on August 6 and October 7, 2025. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of their respective grant dates and in quarterly installments thereafter over the next three years.
  • [F2]On March 18, 2026, in accordance with the terms of the Amended and Restated 2021 Plan, the Board of Directors of the Company approved a repricing of outstanding stock options granted or repriced on October 7, 2025. The exercise price of each repriced option was reduced from $1.10 to $0.37 per share. The option will vest as to 25% of the shares covered by the option on the one-year anniversary of the Grant Date and in quarterly installments thereafter over the next three years.
Signature
/s/ Kitty B. Payne|2026-03-26

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4 FOR 03-18-2026